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Background and purpose: Cinnamaldehyde, a major component of cinnamon, induces the 
generation of reactive oxygen species and exerts vasodilator and anticancer effects, but its short 
half-life limits its clinical use. The present experiments were designed to compare the acute 
relaxing properties of cinnamaldehyde with those of self-assembling polymer micelles either 
loaded with cinnamaldehyde or consisting of a polymeric prodrug [poly(cinnamaldehyde)] that 
incorporates the compound in its backbone.
Methods: Rings of porcine coronary arteries were contracted with the thromboxane A
2
 receptor 
agonist U46619 or 40 mM KCl, and changes in isometric tension were recorded.
Results: Cinnamaldehyde induced concentration-dependent but endothelium-independent, 
nitric oxide synthase (NOS)-independent, cyclooxygenase-independent, soluble guanylyl 
cyclase (sGC)-independent, calcium-activated potassium-independent, and TRPA1 channel-
independent relaxations. Cinnamaldehyde also inhibited the contractions induced by 40 mM KCl 
Ca2+ reintroduction in 40 mM KCl Ca2+-free solution or by the Ca2+ channel opener Bay K8644. 
Cinnamaldehyde-loaded control micelles induced complete, partly endothelium- dependent 
relaxations sensitive to catalase and inhibitors of NOS or sGC, but not cyclooxygenase or 
TRPA1, channels. Cinnamaldehyde-loaded micelles also inhibited contractions induced by 
40 mM KCl Ca2+ reintroduction or Bay K8644. Poly(cinnamaldehyde) micelles induced only 
partial, endothelium-dependent relaxations that were reduced by inhibitors of NOS or sGC and 
by catalase and the antioxidant tiron, but not by indomethacin or TRPA1 channel blockers.
Conclusion: The present f indings demonstrate that cinnamaldehyde-loaded and 
poly(cinnamaldehyde) micelles possess vasodilator properties, but that the mechanism underly-
ing the relaxation that they cause differs from that of cinnamaldehyde, and thus could be used 
both to relieve coronary vasospasm and for therapeutic drug delivery.
Keywords: calcium sensitivity, cinnamaldehyde, L-type Ca2+ channel, NO synthase, micelle-
forming polymeric prodrug, porcine coronary artery
Introduction
Cinnamaldehyde (Figure 1A) is the main component of Cinnamomum zeylanicum or 
Cinnamomum cassia extracts.1,2 It possesses antithrombotic properties in vitro and 
in vivo3 and has anti-inflammatory4,5 and anticancer6 effects. In the kidney, cinnamal-
dehyde decreases the level of nonenzymatic antioxidants and increases the activity of 
antioxidant enzymes.7 The compound also possesses antidiabetic properties in the rat8,9 
and reduces visceral fat deposition in mice fed a high-fat and high-sucrose diet.10
With regard to acute cardiovascular effects, cinnamaldehyde reduces peripheral 
resistance and lowers arterial blood pressure in dogs11 and rats,12 as well as increasing 
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Figure 1 chemical structure of (A) cinnamaldehyde (trans-3-phenyl-2-propenal), (B) control polymer without the incorporation of cinnamaldehyde in its backbone, and 
(C) poly(cinnamaldehyde), a copolymeric prodrug with a backbone containing cinnamaldehyde. (D) The hydrophobic backbone and hydrophilic polyethylene glycol segments 
(n∼10) of the polymers self-assemble to form stable micelles in aqueous solution to control micelles that were loaded with cinnamaldehyde (cinnamaldehyde-loaded micelles, 
top) and poly(cinnamaldehyde) micelles (bottom). 
hind paw blood flow in mice.13 In the latter species, single 
doses of cinnamaldehyde cause biphasic changes in arterial 
blood pressure, with an initial drop followed by a pressor 
response.13 In vitro, cinnamaldehyde induces relaxation 
of rat aortae14,15 and mouse mesenteric arteries.13 Chronic 
(6 weeks) treatment with cinnamaldehyde protects against 
increases in diastolic blood pressure after induction of dia-
betes in Wistar rats.15,16
The oral bioavailability of cinnamaldehyde is limited, and 
the compound has a short biological half-life.17 Therefore, 
to enhance the therapeutic potential of the compound, two 
polymeric prodrugs were designed. One consists of polymer 
without incorporation of cinnamaldehyde in the backbone 
(control polymer)18 that self-assembles to micelles in aque-
ous solution (control micelle) that can be loaded with cin-
namaldehyde in its core (cinnamaldehyde-loaded micelle; 
Figure 1B and D, top).
The second polymeric prodrug incorporates the com-
pound in the polymer backbone [poly(cinnamaldehyde)] and 
also self-assembles to form micelles [poly(cinnamaldehyde) 
micelle; Figure 1C and D, bottom].18 The present experi-
ments compare the vasodilator properties of cinnamalde-
hyde with those of those two types of micelles containing 
cinnamaldehyde.
Materials and methods
Tissue preparation
Porcine hearts were collected from the local slaughterhouse 
(Nonsan, South Korea) and placed in ice-cold Krebs-Ringer 
bicarbonate buffer with the following composition (in mM): 
123 NaCl, 4.7 KCl, 5.5 glucose, 1.2 MgSO
4
, 1.6 CaCl
2
, 1.2 
KH
2
PO
4
, 21 NaHCO
3
, and 0.03 Na
2
EDTA (control solution). 
The main branches of the circumflex coronary arteries were 
dissected free, cleaned of adherent fat and connective tissue, 
cut into rings (approximately 3 mm in length), and stored 
(less than 14 hours) at 4°C until use. In certain rings, the 
endothelium was removed mechanically.19
Isometric tension recording
Recording of isometric tension was performed in a multi-
channel organ chamber system (Panlab SLU, Barcelona, 
Spain). Rings of coronary arteries were transferred to organ 
chambers filled with 10 mL control solution bubbled with 
5% CO
2
 and 95% O
2
 and maintained at 37°C. The prepara-
tions were suspended between a stationary and an adjustable 
stainless steel hook; the latter was connected to an isometric 
force transducer (Harvard Apparatus, Holliston, MA, USA). 
Changes in isometric force were measured, digitalized, dis-
played, recorded, and analyzed with an iWorx Acquisition 
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system (model IX/408) with Labscribe2 software (iWorx 
Systems Inc., Dover, NH, USA) on a computer.
Initial tension was set to approximately 0.5 g and was 
gradually increased to 2.5 g during a 1-hour incubation 
period. To obtain a reference contraction at the beginning 
of the actual experiment, the coronary rings were exposed 
twice to 60 mM KCl buffer solution obtained by equimolar 
substitution of NaCl with KCl.
The rings were incubated with pharmacological agents for 
30 minutes, and concentration-dependent responses to cinna-
maldehyde or dose-dependent responses to control micelles 
(containing no cinnamaldehyde), cinnamaldehyde-loaded 
micelles, or poly(cinnamaldehyde) micelles were measured 
in quiescent preparation or in rings contracted with the stable 
thromboxane A
2
 (TP) receptor agonist 9,11-dideoxy-11α,9α-
epoxymethanoprostaglandin F
2α (U46619 [2 × 10−8 M] 
to reach approximately 50% of the reference contraction 
obtained with 60 mM KCl) solution or with 40 mM KCl 
buffer solution (equimolar substitution for NaCl).
In a subset of experiments, contractions to increasing 
concentrations of Ca2+ (after incubation in Ca2+-free Krebs-
Ringer bicarbonate buffer containing 40 mM KCl to activate 
L-type calcium channels) or to increasing concentrations of 
the pharmacological activator of the L-type Ca2+ channels 
Bay K8644 were obtained in the presence of increasing 
concentrations/doses of cinnamaldehyde or cinnamaldehyde-
loaded micelles.
Polymer synthesis and micelle preparation
Control (polymer without incorporation of cinnamaldehyde 
in its backbone) and poly(cinnamaldehyde) polymers were 
synthesized by a Michael-type addition polymerization, 
as described.18 The micelles were prepared daily by direct 
dissolution. Briefly, polymers were dissolved in  methanol 
(50 mg/mL), and the polymer solution was added to 
 phosphate-buffered saline (pH 7.4). After complete evapora-
tion of methanol, control or poly(cinnamaldehyde) micelles 
approximately 100 nm in size18 were obtained at a concentra-
tion of 10 mg/mL. Micelles loaded with 10% cinnamaldehyde 
were prepared by adding cinnamaldehyde to the methanolic 
polymer solution.
Drugs
U46619, trans-cinnamaldehyde, indomethacin, Nω-Nitro-
L-arginine methyl ester hydrochloride (L-NAME), 
6,12,19,20,25,26-hexahydro-5,27:13,18:21,24-trietheno-
11,7-metheno-7H-dibenzo[b,m][1,5,12,16]tetraazacyclotri-
cosine-5,13-diium ditrifluoroacetate hydrate (UCL 1684), 
1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-
34), glibenclamide, catalase, 4,5-dihydroxy-1,3-ben-
zenedisulfonic acid disodium salt monohydrate (Tiron), 
and hydrogen peroxide (H
2
O
2
) were purchased from 
Sigma-Aldrich Co, LLC (St Louis, MO, USA). (1R)-
(+)-camphor and ruthenium red were purchased from 
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). 
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-
7-yl)-N-(4-isopropylphenyl)acetamide (HC030031) and 
Bay K6844 were purchased from Tocris Bioscience (Bris-
tol, UK). 1H-[1,2,4]oxadiazolo[4,3-a]quinoxal in-1-one 
(ODQ) was purchased from Cayman Chemical Co (Ann 
Arbor, MI, USA). Iberiotoxin was purchased from Bachem 
AG (Bubendorf, Switzerland). Nifedipine was purchased 
from Chunghwa Chemical Synthesis and Biotech Co, Ltd 
(New Taipei City, Taiwan). Indomethacin was dissolved 
in 0.2 M Na
2
CO
3
. UCL 1684, TRAM-34, glibenclamide, 
HC030031, Bay K8644, ODQ, and nifedipine were dis-
solved in dimethylsulfoxide; when dimethylsulfoxide was 
used as a solvent, its concentration was less than 0.1% in the 
organ chambers. All other drugs were dissolved in distilled 
water. The concentrations of drugs are given in molar, and 
those of micelles are given in milligrams per milliliter in 
the bath solution.
calculations and statistical analysis
Contractions are expressed as a percentage of the reference 
response to 60 mM KCl (100%) obtained at the beginning 
of the experiment. Relaxations are expressed as a percentage 
of the contractions to U46619 or 40 mM KCl.
To compare various treatments, areas under the curve 
(AUC) and half maximal effective concentration (EC50) 
values of the individual concentration-response curves were 
calculated with the log-trapezoidal method and nonlinear 
regression analysis, respectively, using GraphPad Prism 6 
software (GraphPad Software Inc., La Jolla, CA, USA).
Data are expressed as means ± standard error of the mean. 
One-way analysis of variance was used to define statistically 
significant differences between groups. Dunnett’s post hoc 
test was used to identify statistically significant differences 
(P,0.05) compared with control.
Results
In quiescent rings, cinnamaldehyde, control micelles, 
cinnamaldehyde-loaded micelles, poly(cinnamaldehyde) 
micelles, and H
2
O
2
 in the concentration/dose ranges used 
(see following) did not cause significant changes in basal 
tension (data not shown).
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cinnamaldehyde
Cinnamaldehyde caused concentration-dependent (and 
complete) relaxations of coronary rings contracted by the 
TP receptor agonist U46619. These relaxations were not 
inhibited significantly by the removal of the endothelium 
(Figure 2A, top) or by L-NAME (10−4 M; inhibitor of nitric 
oxide synthases; Figure 2A, middle) and indomethacin 
(10−5 M; inhibitor of cyclooxygenases), given alone or in 
combination with L-NAME (Table 1). Likewise, the inhibitor 
of soluble guanylyl cyclase ODQ (10−5 M) had no significant 
effect on cinnamaldehyde-induced relaxations (Figure 2A, 
bottom).
Relaxations to cinnamaldehyde were not influenced sig-
nificantly by the nonenzymatic antioxidant tiron (10−3 M) or 
by catalase (1,000 U/mL) (Figure 3A).
The TRPA1 channel inhibitors HC030031 (10−5 M or 
10−4 M),20 ruthenium red (10−4 M),21 or camphor (10−4 M)22 
did not significantly affect the response to cinnamaldehyde 
(Table 1).
Inhibitors of small- and intermediate-conductance 
Ca2+-activated potassium channels (UCL 1684 plus TRAM 
34, respectively; 10−5 M each, given in combination), 
of large-conductance Ca2+ activated potassium channels 
(iberiotoxin; 10−7 M), or of adenosine triphosphate (ATP)-
dependent potassium channel (glibenclamide; 10−6 M) did 
not significantly inhibit cinnamaldehyde-induced relaxations 
(Table 1).
Cinnamaldehyde also caused a concentration-dependent 
inhibition of the contractions of coronary arteries without 
endothelium, caused by 40 mM KCl (Figure 4A). The 
potency of cinnamaldehyde was significantly less in 40 mM 
KCl than in U46619-contracted preparations, as reflected 
by the comparison of the calculated EC50 values from 
the concentration–relaxation curves (log[EC50], 40 mM 
KCl: −3.22±0.06 [Figure 4A] vs U46619: −3.76±0.06 
 [Figure 2A, top, control]; P,0.05). Nifedipine (10−7 M) and 
cinnamaldehyde (32–320 × 10−9 M) inhibited the contrac-
tions induced by Ca2+ reintroduction after incubation in 40 
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Figure 2 effect of endothelium removal (top), nitric oxide synthase inhibitor l-NaMe (middle), and soluble guanylyl cyclase inhibitor ODQ (bottom) on the relaxations 
induced by (A) increasing concentrations of cinnamaldehyde (n=6–9) and increasing amounts of (B) cinnamaldehyde-loaded micelles (n=8–10) and (C) poly(cinnamaldehyde) 
micelles (n=10) in porcine coronary artery rings contracted with 2 × 10−8 M U46619. Data are expressed as means ± standard error of the mean. *Statistically significant 
differences (P,0.05) from controls.
Abbreviations: l-NaMe, Nω-Nitro-l-arginine methyl ester hydrochloride; ODQ, 1h-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
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Table 1 aUc and ec50 values for cinnamaldehyde concentration-response curves and aUc values of the dose-response curves to 
cinnamaldehyde-loaded and poly(cinnamaldehyde) micelles
Cinnamaldehyde Cinnamaldehyde- 
loaded micelles
Poly(cinnamaldehyde) 
micelles
AUC log(EC50) AUC AUC
control 110.0±6.8 (n=6) −3.69±0.04 197.4±19.8 (n=17) 94.6±7.0 (n=20)
 +10 μM indomethacin 119.3±3.4 −3.72±0.05 185.8±11.8 (n=10) 81.2±9.6 (n=10)
 +10 μM indomethacin +100 μM l-NaMe 118.7±6.3 −3.62±0.03 147.9±6.4* (n=7) 69.1±7.5* (n=10)
control 142.3±7.3 (n=17) −4.06±0.08 225.2±13.8 (n=11) 112.8±9.0 (n=9)
 +10 μM hc030031 174.7±4.3* −4.40±0.10* 240.3±10.0 107.2±11.9
control 162.8±30.5 (n=4) −4.22±0.24
 +100 μM hc030031 137.4±12.9 −4.06±0.11
control 128.3±8.3 (n=8) −3.91±0.07 79.2±5.4 (n=7)
 +100 μM ruthenium red 114.4±7.2 −3.77±0.08 63.7±7.9
control 137.7±17.5 (n=8) −4.02±0.15
 +100 μM camphor 127.2±15.8 −3.91±0.17
control 108.0±6.1 (n=4) −3.81±0.08
 +10 μM Ucl1684 +10 μM TraM-34 114.3±11.6 −3.75±0.05
control 133.8±10.1 (n=4) −4.00±0.08
 +100 nM iberiotoxin 161.7±12.5 −4.19±0.12
control intact 138.4±11.3 (n=10) −4.00±0.12
 +1 μM glibenclamide 183.5±9.3* −4.36±0.10*
control-endothelium 158.8±10.2 (n=9) −4.15±0.08
 +1 μM glibenclamide 181.1±13.4 −4.39±0.12
Notes: Porcine coronary artery rings contracted with U46619 (2 × 10−8 M) and preincubated with various pharmacological agents. Data are expressed as mean ± standard 
error of the mean. *Statistically significant differences (P,0.05) from controls.
Abbreviations: aUc, area under the curve; ec50, half maximal effective concentration; l-NaMe, Nω-Nitro-l-arginine methyl ester hydrochloride; TraM-34, 
1-[(2-chlorophenyl)diphenylmethyl]-1h-pyrazole.
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mM KCl Ca2+-free solution (Figure 5A) or in response to 
increasing concentrations of the L-type Ca2+ channel opener 
Bay K8644 (Figure 5B).
cinnamaldehyde-loaded micelles
Cinnamaldehyde-loaded micelles, but not control micelles 
prepared from the polymer without incorporation of cinnam-
aldehyde (data not shown), caused dose-dependent and com-
plete relaxations of the coronary rings; the initial phase of the 
relaxation (caused by 10−3 to 10−1 mg/mL) was prevented by 
endothelium removal (Figure 2B, top). L-NAME (Figure 2B, 
middle), but not indomethacin (Table 1), significantly 
inhibited the relaxation induced by cinnamaldehyde-loaded 
micelles. ODQ inhibited the initial phase of this relaxation 
(Figure 2B, bottom), which was also inhibited by catalase, 
but not by tiron (Figure 3B) or HC030031 (Table 1).
Cinnamaldehyde-loaded micelles caused a dose-
 dependent inhibition of the contractions caused by 40 mM 
KCl in coronary arteries without endothelium (Figure 4B). 
Although the lowest dose (0.1 mg/mL) of cinnamaldehyde-
loaded micelles tested was without effect, a higher dose 
(1 mg/mL) significantly inhibited the contractions induced 
by Ca2+ reintroduction in 40 mM KCl Ca2+-free solution 
(Figure 5C); both doses inhibited the increases in tension 
caused by Bay K8644 (Figure 5D).
Poly(cinnamaldehyde) micelles
Poly(cinnamaldehyde) micelles also caused dose-dependent 
partial relaxations of the coronary rings (Figure 2C). The 
relaxations to poly(cinnamaldehyde) micelles were abol-
ished by endothelium removal (Figure 2C, top), by L-NAME 
(Figure 2C, middle), and by ODQ (Figure 2C, bottom), but they 
were not influenced significantly by indomethacin (Table 1).
Relaxations to poly(cinnamaldehyde) micelles were 
inhibited both by catalase and tiron (Figure 3C) but were 
not affected significantly by either HC030031 or ruthenium 
red (Table 1).
Nifedipine and hydrogen peroxide
Nifedipine relaxed 40 mM KCl-contracted coronary 
rings more potently than those contracted with U46619 
(Figure 6).
In U46619-contracted coronary artery rings, H
2
O
2
 caused 
a slight, nonsignificant initial increase in tension (data not 
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Figure 5 effect of cinnamaldehyde and nifedipine (used as a reference compound to inhibit contractions (A and B, n=10–16) and cinnamaldehyde-loaded micelles (C 
and D, n=9–10) on contractions induced by ca2+ reintroduction in 40 mM Kcl solution (A and C) and on contractions induced by the l-type ca2+ channel opener Bay 
K8644 (B and D). Data are expressed as means ± standard error of the mean. *Statistically significant differences (P,0.05) from control resulting from cinnamaldehyde or 
cinnamaldehyde-loaded micelles. †Statistically significant differences (P,0.05) from control resulting from nifedipine.
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shown), followed by a concentration-dependent relaxation 
that was abolished by catalase (Figure 7).
Discussion
The present study compared the vascular effects of cin-
namaldehyde in porcine coronary arteries with the effects 
in two types of cinnamaldehyde-containing micelles that 
were developed to enhance the therapeutic potential of the 
compound.
cinnamaldehyde
The vasodilator response to cinnamaldehyde itself was ana-
lyzed first. The present results confirm that the compound, 
given acutely in vitro, causes relaxation of isolated arteries.13–15 
*
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(n=8). Data are expressed as means ± standard error of the mean. *statistically 
significant differences (P,0.05) between experimental groups.
Abbreviation: ec50, half maximal effective concentration.
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Figure 7 effect of catalase on h2O2 induced relaxations in porcine coronary arterial 
rings contracted with U46619 (2 × 10−8 M). Data are expressed as means ± standard 
error of the mean (n=8). *Statistically significant differences (P,0.05) from control.
The results demonstrate that the relaxation of contracted 
porcine coronary arterial rings is endothelium-independent. 
The response is insensitive to inhibitors of NOS and soluble 
guanylyl cyclase, as also reported in the rat aorta,15 although 
in the latter preparation, partial reduction of the relaxation 
with endothelium removal or NOS inhibition has been 
reported.14 Likewise, a contribution of cyclooxygenase 
products to the relaxation induced by cinnamaldehyde can 
be excluded, as indomethacin (alone or in combination with 
L-NAME) was without effect, as seen in different aortic 
preparations of the rat.14,15 Furthermore, relaxations to cin-
namaldehyde were also resistant to inhibitors of hyperpolar-
izing (small- [UCL 1684],23 intermediate- [TRAM-34],24 and 
large- conductance [iberiotoxin]25), Ca2+-activated, or ATP-
dependent (glibenclamide)26 potassium channels.
Cinnamaldehyde may be a natural agonist of TRPA1 
channels.1,27,28 The superfamily of TRP channels includes 
ankyrin (TRPA1), which is expressed and physiologically 
active in a variety of cell types.29–33 TRPA1 channels found 
in the vascular cells28,34 can be activated by several physical 
and chemical stimuli,1,28,33–36 Because of their nonselective 
cation permeability,29–33 they can modulate the function of 
both vascular smooth muscle and endothelial cells by acting 
as depolarizing electrogenic channels and/or as a Ca2+ entry 
route.29–32 In the mouse, single doses of cinnamaldehyde 
cause biphasic, TRPA1-dependent changes in arterial blood 
pressure, with an initial drop followed by a pressor response.13 
Vasodilatation induced by TRPA1 activation involves the 
interactions of more than one cell type in the vascular 
wall.28,34 However, the deletion of TRPA1 channels does not 
completely eliminate the relaxation to cinnamaldehyde in 
mouse mesenteric arteries,13 which raises the possibility that 
TRPA1 channels are not solely responsible for the vascular 
responses to the compound. The present results comfort the 
latter interpretation, as they demonstrate that relaxations 
induced by cinnamaldehyde in porcine coronary arteries 
are not influenced by TRPA1 channel inhibitors.20–22 Thus, 
unlike in other vascular areas,13,37 in porcine coronary arter-
ies, cinnamaldehyde-induced relaxations are independent of 
TRPA1 channel activation. They appear, rather, to involve 
reduction in smooth muscle Ca2+ sensitivity and/or inhibition 
of voltage-gated Ca2+ channels.
The first conclusion is based on the observation that 
cinnamaldehyde, unlike nifedipine, relaxed U46619 con-
tracted rings more potently than preparations stimulated 
with 40 mM KCl. This observation is in line with the find-
ing that Ca2+ sensitization is for the major contributor to the 
U46619-induced contractions of porcine coronary arteries.38 
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The second  interpretation is supported by the observations 
that the compound, similar to nifedipine, concentration-
dependently inhibited contractions in response to 40 mM 
KCl solution, as also seen in rat aortae.14,15 High KCl solution 
contracts porcine coronary arteries by inducing depolariza-
tion and elevating the myoplasmic Ca2+ concentration without 
affecting smooth muscle Ca2+ sensitivity.38 The experiments 
demonstrating that the compound inhibited contractions 
induced by either reintroduction of Ca2+ after depletion of the 
activator ion in 40 mM KCl solution or the voltage-dependent 
Ca2+ channel activator Bay K864439 further support an 
inhibitory effect on voltage gated Ca2+ channels.
cinnamaldehyde-containing micelles
Cinnamaldehyde-loaded micelles also caused com-
plete relaxation of the coronary arterial rings, whereas 
poly(cinnamaldehyde) micelles caused only partial relaxation 
(60%–80%).
Endothelium removal and incubation with L-NAME 
caused only partial inhibition of the relaxations induced by 
cinnamaldehyde-loaded micelles, whereas relaxations to 
poly(cinnamaldehyde) micelles were completely dependent 
on the presence of endothelium and NOS activation. In 
both cases, the NOS activation and endothelium-dependent 
NO release must lead to relaxation of the vascular smooth 
muscle after stimulation of soluble guanylyl cyclase, as ODQ, 
a selective inhibitor of the enzyme,40 reduced the relaxations to 
cinnamaldehyde-loaded micelles and poly(cinnamaldehyde) 
micelles to the same extent as endothelium removal or 
inhibition of NOS. The present results do not explain why 
micelles containing cinnamaldehyde in one form or the other, 
but not control micelles not containing the compound, exert 
endothelium-dependent effects. However, we assume that 
because of the size of the micelles (∼100 nM), they can be 
internalized by the endothelial cells, where they undergo 
intracellular acidic/lysosomal dissociation, as seen in vitro,18 
leading to the release of cinnamaldehyde and micelle-forming 
polymer and/or its degradation product or products. The cin-
namaldehyde delivery from the core of the control micelles 
seems to be essential for NOS stimulation and NO produc-
tions, as such an endothelium-dependent component of the 
relaxations was absent when cinnamaldehyde or unloaded 
control micelles were applied alone.
The present results also indicate that in the case of cin-
namaldehyde-loaded micelles, the compound released from 
the micelles is responsible for the endothelium-independent 
component of the observed complete relaxation, as it appears 
to be a result of both reduced Ca2+ sensitivity and inhibition 
of calcium influx through voltage-dependent channels. The 
latter conclusion is based on the observation that cinnamal-
dehyde-loaded micelles inhibited the contractions induced 
by 40 mM KCl solution and Ca2+ reintroduction in Ca2+-free 
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Figure 8 cinnamaldehyde and micelles containing cinnamaldehyde relax coronary arteries with distinct mechanisms. cinnamaldehyde inhibits ca2+ influx and reduce Ca2+ 
sensitivity of vascular smooth muscle cells (left), whereas micelles containing the polymeric prodrug poly(cinnamaldehyde) cause endothelium-dependent relaxation by 
releasing NO and h2O2 (right). Micelles loaded with cinnamaldehyde cause relaxation, using both mechanisms (middle). Thus, both micelles could be used to relieve coronary 
vasospasm and for therapeutic drug delivery.
Abbreviations: eNOs, endothelial nitric oxide synthase; sOD, superoxide dismutase; sgc, soluble guanylyl cyclase; cgMP, cyclic guanosine monophosphate.
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relaxation of coronary arteries by cinnamaldehyde and cinnamaldehyde-containing micelles
40 mM KCl solution, as well as those by Bay K8644, in an 
identical manner to that of cinnamaldehyde itself.
In the case of poly(cinnamaldehyde) micelles, the relax-
ations were completely dependent on the presence of the 
endothelium and on the activity of NOS, without a smooth 
muscle-dependent component. The mechanism underlying 
the activation of endothelial NOS may be similar to that 
assumed for cinnamaldehyde-loaded micelles, whereby 
cinnamaldehyde is released by the degradation of the 
polymeric backbone.18 In addition to the generation of NO, 
poly(cinnamaldehyde) micelles (and cinnamaldehyde-loaded 
micelles to a lesser extent) appear to induce the production of 
H
2
O
2
, as tiron (scavenger of superoxide anions, the precur-
sors of H
2
O
2
)41 and catalase (enzyme metabolizing H
2
O
2
)42 
inhibited the initial phase of the endothelium-dependent 
relaxations. The present experiments demonstrate that, 
indeed, catalase abolishes the relaxant effect of H
2
O
2
 in 
the porcine coronary artery. The production of H
2
O
2
 is not 
incompatible with NOS-dependency, as this enzyme can 
generate H
2
O
2
 in amounts causing endothelium-dependent 
relaxations.43,44
Conclusion
Cinnamaldehyde, whether given directly or delivered by 
micelles containing the compound in their core, induces 
endothelium-independent relaxation of coronary vascular 
smooth muscle by inhibiting Ca2+ sensitivity and Ca2+ influx 
(Figure 8). Micelles containing the compound, either in their 
core or as part of their polymer backbone, cause endothelium-
dependent, NOS-dependent relaxations mediated by NO 
(causing activation of soluble guanylyl cyclase in vascular 
smooth muscle) and possibly H
2
O
2
 (Figure 8). Thus, both 
micelles could be used for drug delivery to relieve coronary 
vasospasm.
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